Effects of ABCG2 and SLCO1B1 gene variants on inflammation markers in patients with hypercholesterolemia and diabetes mellitus treated with rosuvastatin
Dan Zhang, Yangming Ding, Xiaoxue Wang, Wenyu Xin, Wenwen Du, Wenqian Chen, Xianglin Zhang, Pengmei Li
Topics & Concepts
SLCO1B1Single-nucleotide polymorphismRosuvastatinInflammationPharmacogeneticsDiabetes mellitusInternal medicineMedicinePharmacologyEndocrinologyGenotypeBiologyGeneGeneticsDrug Transport and Resistance MechanismsCholesterol and Lipid MetabolismCancer, Lipids, and Metabolism